CAMBRIDGE, Mass., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2019. “EXONDYS 51® (eteplirsen) enjoyed …
TORONTO and NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Frederator Studios, part of WOW! Unlimited Media’s (TSX-V: WOW / OTCQX: WOWMF) leading next generation kids and youth entertainment business, announced today plans to greatly expand its Frederator …
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- PeerStream, Inc. (“PeerStream,” the “Company,” “we,” “our” or “us”) (OTCQB: PEER), a communications software innovator developing enhanced security and privacy solutions for multimedia communication and data …
NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the “Company”) announces its third quarter 2019 financial results. Recent Developments The Company has filed a combined registration statement and proxy statement …
- Third quarter GOCOVRI® product sales of $13.9 million; total prescriptions grew to approximately 6,640 - Topline results from INROADS Phase 3 study of ADS-5102 (GOCOVRI) for walking impairment in patients with multiple sclerosis (MS) expected second half …
SANTA CLARA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial …
TORONTO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging (“MRI”), thermal …
SANTA MONICA, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- TrueCar, Inc. (NASDAQ: TRUE) today announced its financial results for the third quarter ended September 30, 2019. Third Quarter 2019 Financial Highlights Third quarter total revenue down 3.2% from a …
Acquisition will expand commercial presence and market opportunity in Brazil MEDFORD, N.Y., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today …
PLEASANTON, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today reported financial results for the third quarter ended September 30, 2019. Recent Highlights Revenue of $61.2 million for the third quarter of 2019, representing …
REDWOOD CITY, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, …
Workers build an anti-landslide concrete wall on a Jamaican highway: infrastructure spending has gained momentum during the country's economic reform program (photo: iStock/Debbie Ann Powell) November 7, 2019 Jamaica has successfully concluded its …
- Revenue Growth of 15% Powered by 51% Increase in Finished Jewelry Sales - - Double Digit Revenue Gain in Online Channels Segment from Direct-to-Consumer Success - - charlesandcolvard.com Sales Up 31% Contributed to Robust Gross Margin of 49% - - …
DENVER, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Extraction Oil & Gas, Inc. (NASDAQ: XOG) (“Extraction” or the “Company”) today reported financial and operational results for the third quarter of 2019, provided revised 2019 guidance and provided preliminary …
TORONTO, Nov. 07, 2019 (GLOBE NEWSWIRE) -- DREAM OFFICE REAL ESTATE INVESTMENT TRUST (D.UN-TSX) or (“Dream Office REIT”, the “Trust” or “we”) today announced its financial results for the three and nine months ended September 30, 2019. FINANCIAL HIGHLIGHTS …
Activation of innate immunity to target EGFR-expressing solid tumors has potential to address limitations associated with currently available EGFR-targeted therapies Initiation of Phase 1/2a clinical trial expected in first half of 2020 Heidelberg, Germany …
Genentech exercises its final option for an exclusive target selection under ongoing, multi-program strategic oncology collaboration The exclusive target selection triggers a payment in an undisclosed amount to Affimed from Genentech Heidelberg, Germany, …
Announced positive data from two Phase 1 clinical trials of MRG-110 Remain on track to announce interim top-line data from its Phase 2 clinical trial of remlarsen in keloids by year end Implemented restructuring to focus resources primarily on the …
SAINT LAURENT, Quebec, Nov. 07, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today reported financial results for the third quarter ended …
Stephens Nashville Conference on November 13 Jefferies 2019 London Healthcare Conference on November 21 NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, …
